The popular chemotherapy drug Taxotere, also known by its generic name docetaxel, may cause permanent hair loss, baldness or alopecia in cancer patients.
The manufacturer of the drug has not properly warned patients of this risk, thus depriving them of the option to choose other chemotherapy drugs that are just as effective but do not carry the risk of permanent hair loss.Another similar drug called Taxol was available to patients that is just as effective and does not cause long term baldness.
With more than 18 years of experience successfully representing the injured, we can help you get the compensation you deserve for your suffering.
Taxotere Permanent Hair Loss
Taxotere is an injectable product commonly used in chemotherapy treatment to treat breast cancer and other cancers such as prostate, lung, stomach and head/neck cancers.
Though hair loss is a common symptom of chemotherapy, permanent hair loss is much less common and can have a profound effect on patients, leading to poorer quality of life and the appearance that they are still fighting the disease.
Lawsuits are beginning to be filed against the company by affected patients claiming a variety of damages. There have been no large settlements on Taxotere claims to date, but it does not mean that there is no hope. One can also visit www.taxoterehairlawsuit.com/taxotere-lawsuit-lawyers.aspx to get more information about hair loss lawsuits.
It is still a relatively new topic and many lawsuits are actively pending following extensive discovery into scientific research and information affirmatively linking Taxotere to the permanent hair loss suffered by so many patients. As more research is uncovered and a clear link is established, more and more patients will likely have a claim against Sanofi.